HOME >> BIOLOGY >> NEWS
Gene therapy reaches muscles throughout the body and reverses muscular dystrophy in animal model

Researchers have found a delivery method for gene therapy that reaches all the voluntary muscles of a mouse including heart, diaphragm and limbs and reverses the process of muscle-wasting found in muscular dystrophy.

"We have a clear 'proof of principle' that it is possible to deliver new genes body-wide to all the striated muscles of an adult animal. Finding a delivery method for the whole body has been a major obstacle limiting the development of gene therapy for the muscular dystrophies. Our new work identifies for the first time a method where a new dystrophin gene can be delivered, using a safe and simple method, to all of the affected muscles of a mouse with muscular dystrophy," said Dr. Jeffrey S. Chamberlain, professor of neurology and director of the Muscular Dystrophy Cooperative Research Center at the University of Washington School of Medicine in Seattle. He also has joint appointments in the departments of medicine and biochemistry.

Chamberlain is the senior author of the paper describing the results, which will be published in the August edition of Nature Medicine. The paper describes a type of viral vector, a specific type of an adeno-associated virus (AAV), which is able to 'home-in' on muscle cells and does not trigger an immune system response. The delivery system also includes use of a growth factor, VEGF, that appears to increase penetration into muscles of the gene therapy agent. Chamberlain said the formula was the result of about a year of trying different methods.

Duchenne muscular dystrophy is an X-linked genetic disorder that strikes one of every 3,500 newborn boys. The genetic disorder eliminates production of the dystrophin protein, which is necessary for the structural support of muscle. Without this protein, muscles weaken to the point where the victim cannot survive.

"By giving one single injection of this AAV vector carrying
'"/>

Contact: Walter Neary
wneary@u.washington.edu
206-685-1323
University of Washington
25-Jul-2004


Page: 1 2

Related biology news :

1. Targeted therapy knocks out pediatric brain cancer in mice
2. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
3. Columbia research to examine gene influence on severity of peridontal disease, therapy response
4. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
5. The search for a kinder, gentler chemotherapy
6. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
7. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
8. Gene changes linked to increased eye pressure may have implications for glaucoma therapy
9. Jefferson Lab detector technology aids development of cystic fibrosis therapy
10. Stroking up cellular therapy
11. Smart gene therapy protects against damage from heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/26/2019)... ... , ... World Cord Blood Day (WCBD) takes place on November 15, 2019, ... the current and future uses of cord blood stem cells, and the potential cord ... and cure over 80 different life-threatening diseases, including leukemia, lymphoma, and sickle cell anemia. ...
(Date:10/26/2019)... (PRWEB) , ... October 24, 2019 , ... THE PRINCESS ... only been the standard choice for female providers, they were the only choice. Women ... the breasts, or a loose garment that can allow harmful radiation to penetrate the ...
(Date:10/26/2019)... , ... October 25, 2019 , ... ... on myofunctional therapy in La Plata, MD. Orofacial myofunctional disorders (OMDs) are abnormal ... eats, sleeps and speaks. This can include anything from difficulty swallowing and limited ...
Breaking Biology News(10 mins):
(Date:10/15/2019)... ... ... tech PR agency at the epicenter of the future of PR, today announced that it ... Ragan’s Health Care PR & Marketing Awards. This award marks the second consecutive year ARPR ... healthIT practice group grew by 18 percent in Q3 this year, driven by client renewals, ...
(Date:10/10/2019)... VEGAS (PRWEB) , ... October 10, 2019 , ... R3 ... courses. The next course is October 18-19th, 2019 in Las Vegas with spots still ... exosomes. He completed training at several Ivy League universities including Cornell, Harvard and Dartmouth. ...
(Date:10/8/2019)... ... October 07, 2019 , ... Erchonia ... therapy technology (“3LT®”), today announces that the U.S. Food and Drug Administration (FDA) ... laser for the temporary relief of chronic neck and shoulder pain of musculoskeletal ...
(Date:10/3/2019)... POWAY, Calif. (PRWEB) , ... October 01, 2019 , ... ... owner’s riding program. Mimi, Cheyenne’s owner, owns and operates Rebel’s Run , ... Cheyenne was a favorite amongst students and trail riding guests. Mimi describes her ...
Breaking Biology Technology:
Cached News: